Evidence map›Paper›PMID 36696194›Full record

ArticleJournal of thrombosis and haemostasis : JTH2023

Variability in International Society on Thrombosis and Haemostasis-Scientific and Standardization Committee endorsed Bleeding Assessment Tool (ISTH-BAT) score with normal aging in healthy females: contributory factors and clinical significance.

Dearbhla Doherty, Julie Grabell, Pamela A Christopherson, Robert R Montgomery, Barry S Coller, Michelle Lavin, James S O'Donnell, Paula D James, Zimmerman Program Investigators

Open access · hybridAbstract read
In one paragraph

Article in Journal of thrombosis and haemostasis : JTH, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
10.2field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 35 citations in OpenAlex.

  1. Seventh Åland Island Meeting on von Willebrand Disease.Haemophilia : the official journal of the World Federation of Hemophilia · 2026
    Article
  2. Observational
  3. Review
  4. Review
  5. Von Willebrand disease: A century of progress.Research and practice in thrombosis and haemostasis · 2026
    Review
  6. Article
  7. Article
  8. Review
  9. Bleeding assessment tools and quality of life in bleeding disorder of unknown cause.Research and practice in thrombosis and haemostasis · 2026
    Article
  10. Article
  11. Predictors for future bleeding in bleeding disorder of unknown cause.Hematology. American Society of Hematology. Education Program · 2025
    Review
  12. Diagnosis of bleeding disorder of unknown cause: how many tests are enough to diagnose BDUC?Hematology. American Society of Hematology. Education Program · 2025
    Review
  13. Review
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 6 institutions in 3 countries.

Dearbhla DohertyNational Coagulation Centre, St James's Hospital, Dublin, Ireland; Irish Centre for Vascular Biology, School of Pharmacy and Biomolecular Sciences, Royal College of Surgeons in Ireland, Dublin, Ireland. Electronic address: Dearbhladoherty20@rcsi.ie.
Julie GrabellDepartment of Medicine, Queen's University, Kingston, Ontario, Canada.
Pamela A ChristophersonBlood Research Institute, Versiti, Milwaukee, WI, USA.
Robert R MontgomeryBlood Research Institute, Versiti, Milwaukee, WI, USA; Children's Research Institute, Medical College of Wisconsin, Milwaukee, WI, USA.
Barry S CollerAllen and Frances Adler Laboratory of Blood and Vascular Biology, Rockefeller University, NY, USA.
Michelle LavinNational Coagulation Centre, St James's Hospital, Dublin, Ireland; Irish Centre for Vascular Biology, School of Pharmacy and Biomolecular Sciences, Royal College of Surgeons in Ireland, Dublin, Ireland.
James S O'DonnellNational Coagulation Centre, St James's Hospital, Dublin, Ireland; Irish Centre for Vascular Biology, School of Pharmacy and Biomolecular Sciences, Royal College of Surgeons in Ireland, Dublin, Ireland; National Children's Research Centre, Our Lady's Children's Hospital Crumlin, Dublin, Ireland.
Paula D JamesDepartment of Medicine, Queen's University, Kingston, Ontario, Canada.
Zimmerman Program Investigators
Queen's University · CASt. James's Hospital · IEChildren's Hospital of Wisconsin · USRockefeller University · USRoyal College of Surgeons in Ireland · IEVersiti Blood Center of Wisconsin · US

Funding

Developing, Demonstrating, and Disseminating Innovative Programs to Achieve Translational SuccessUL1TR001866 · NCATS · ROCKEFELLER UNIVERSITY · PI COLLER, BARRY, KRUEGER, JAMES G · 2016 to 2025
$40.6M
Zimmerman Program for the Molecular and Clinical Biology of VWDP01HL081588 · NHLBI · VERSITI WISCONSIN, INC. · PI MONTGOMERY, ROBERT R · 2005 to 2016
$19.3M
Zimmerman Program on the Biology of VWDP01HL144457 · NHLBI · VERSITI WISCONSIN, INC. · PI MONTGOMERY, ROBERT R · 2019 to 2023
$13.3M
NCATS NIH HHS UL1 TR001866NHLBI NIH HHS P01 HL081588NHLBI NIH HHS P01 HL144457Wellcome TrustWellcome Trust 203930/B/16/Z
6 · The paper itself

Abstract

backgroundBleeding assessment tools are key screening tests used in the evaluation of patients with suspected inherited bleeding disorders. The International Society on Thrombosis and Haemostasis-Scientific and Standardization Committee endorsed Bleeding Assessment Tool (ISTH-BAT) has differing reference ranges for adult males (0-3), adult females (0-5), and children (0-2), reflecting differing bleeding symptoms and exposure to hemostatic challenges in these healthy population subgroups. Age is known to markedly impact bleeding score in individuals with von Willebrand disease. However, the influence of age on bleeding score in healthy adult controls is poorly understood.

objectivesWe aimed to assess variability in ISTH-BAT score with age among healthy control females.

methodsWe used the legacy "Merging Project" dataset of normal healthy controls upon which current ISTH-BAT normal ranges are based. We included women, totaling 646 individuals. The normal range (middle 95th percentile) of total ISTH-BAT and grouped subdomain scores between age quartiles was assessed.

resultsThe normal range of ISTH-BAT scores increased with age, ranging from 0 to 4 in the youngest quartile (age range, 18-30) to 0 to 6 in the oldest (age range, 52-88). This increased variability with aging was related both to high menorrhagia domain scores in older women and an increase in postprocedural bleeding with accumulated exposure to hemostatic challenges.

conclusionsCumulatively, our data highlight that normal aging leads to increased variability in bleeding scores in healthy adult females. Further refinement of the ISTH-BAT with age-adjusted reference ranges may improve the sensitivity and specificity of the tool among females.

Indexed as

HemostaticsThrombosisAdolescentAdultAgedAged, 80 and overAgingChildClinical RelevanceFemaleHemorrhageHemostasisHumansMaleMiddle AgedYoung AdultHemostaticsblood coagulation disordersdecision support techniqueshemorrhageinheritedmenorrhagiavon Willebrand diseases

Identifiers

PMID36696194
PMCPMC11008594
OpenAlexW4313730630

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.